ONCHILLES PHARMA
Onchilles Pharma is a biotechnology company developing first-in-class biologics therapies for the treatment of cancer. The company's drug selectively targets cancer cells and is non-toxic to normal cells and tissues, helping medical professionals treat cancer patients efficiently. It was founded in 2017 and is headquartered in San Diego, California.
ONCHILLES PHARMA
Social Links:
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2017-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.onchillespharma.com
Total Employee:
1+
Status:
Active
Total Funding:
7.15 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Global Site Tag Sitelinks Search Box Organization Schema
Similar Organizations
Adamis Pharmaceuticals
Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.
Alios BioPharma
Alios BioPharma is a biotechnology company developing novel medicines for the treatment of viral diseases.
Asklepios BioPharmaceutical
Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Eidos Therapeutics
Eidos Therapeutics is a clinical-stage biotech company developing novel, genetically targeted therapies to improve the lives of patients.
OncoMed Pharmaceuticals
OncoMed Pharmaceuticals is a biotechnology company developing novel therapeutics for the treatment of cancer.
Seneca Therapeutics
Seneca is a biotechnology company that focuses on developing novel oncolytic immunotherapeutics for the treatment of cancer.
TargED Biopharmaceuticals
TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.
Vor Biopharma
Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.
Current Employees Featured
Founder
Investors List
LYZZ Capital
LYZZ Capital investment in Series A - Onchilles Pharma
UChicago Startup Investment Program
UChicago Startup Investment Program investment in Series A - Onchilles Pharma
The University of Chicago Innovation Fund
The University of Chicago Innovation Fund investment in Grant - Onchilles Pharma
Key Employee Changes
| Date | New article |
|---|---|
| 2021-10-26 | Onchilles Pharma Appoints Christopher Twitty, Ph.D., Chief Scientific Officer |
Official Site Inspections
http://www.onchillespharma.com Semrush global rank: 4.42 M Semrush visits lastest month: 2.51 K
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.186
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Onchilles Pharma"
Home | Onchilles Pharma Pan-cancer Therapeutics
Onchilles Pharma pioneers the ELANE pathway to develop next-generation pan-cancer therapies. Explore our biologic pipeline for head & neck, skin, breast, and lung cancers, with first-in …See details»
Onchilles Pharma - Crunchbase Company Profile & Funding
Onchilles Pharma is a biotechnology company developing first-in-class biologics therapies for the treatment of cancer. The company's drug selectively targets cancer cells and is non-toxic to …See details»
Onchilles Pharma - LinkedIn
Onchilles Pharma | 2,510 followers on LinkedIn. Developing drug candidates that have the potential to be broadly effective against a wide range of cancers. | Onchilles Pharma was founded on ...See details»
Onchilles Pharma - PitchBook
Www.onchillespharma.com. Ownership Status. Privately Held (backing) Financing Status. Venture Capital-Backed. Corporate Office. 9880 Campus Point Drive; …See details»
Onchilles Expands Leadership Team to Advance First-in-Class Pan …
January 13, 2024SAN DIEGO, January 13, 2024 – Onchilles Pharma, a private biotech company pioneering pan-cancer therapeutics that harness the ELANE pathway – a novel innate immune …See details»
Onchilles Pharma - Products, Competitors, Financials, Employees ...
Headquarters Location. 9880 Campus Point Drive Suite 420. San Diego, California, 92121, United States. 202-256-4334See details»
Onchilles Pharma Announces Presentation of Preclinical Data for …
SAN DIEGO, March 14, 2023 – Onchilles Pharma, a private biotech company developing new cancer therapeutics that leverage myeloid biology, announced today the presentation of …See details»
Onchilles Pharma - Company Profile - Tracxn
Feb 25, 2025 Onchilles Pharma - Developer of small molecule therapeutics for cancer. Raised a total funding of $7M over 1 round from 1 investor. Founded by Court Turner and Lev Becker in …See details»
Onchilles Pharma, Inc. - Drug pipelines, Patents, Clinical trials
For more info, visit . Contacts Company: Peter Haberz, Ph.D., Vice President, Corporate Development, [email protected] Media: Jessica Yingling, Ph.D., Little Dog …See details»
Onchilles Pharma - VentureRadar
Website: http://onchillespharma.com/ Develops a pipeline of first-in-class biologic drug candidates based on breakthrough research on an anticancer protein released ...See details»
Onchilles Pharma - Overview, News & Similar companies - ZoomInfo
Onchilles Pharma Announces Presentation of Data for N17350 Program at SITC 2023 SAN DIEGO--(BUSINESS WIRE)-- #biotech--Onchilles Pharma, a private biotech company …See details»
Onchilles Pharma - VentureRadar
Onchilles Pharma was founded on breakthrough research that was the first to describe that human neutrophils release a major anticancer protein,... ... Find out more ...See details»
Onchilles Pharma | CipherBio
Explore Onchilles Pharma's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
Meet our team - ONCHILLES PHARMA
Jan 13, 2024 Onchilles Pharma pioneers the ELANE pathway to develop next-generation pan-cancer therapies. Explore our biologic pipeline for head & neck, skin, breast, and lung cancers, …See details»
Onchilles Expands Leadership Team - firstwordpharma.com
Jan 13, 2025 SAN DIEGO--(BUSINESS WIRE)-- Onchilles Pharma, a private biotech company pioneering pan-cancer therapeutics that harness the ELANE pathway – a novel innate immune …See details»
Onchilles Pharma Nominates First Drug Development Candidate …
Dec 12, 2022 SAN DIEGO--(BUSINESS WIRE)--Onchilles Pharma, a private biotech company developing new cancer therapeutics to modulate myeloid biology, announced today the …See details»
Onchilles Expands Leadership Team to Advance First-in-Class Pan …
Jan 13, 2025 Onchilles Expands Leadership Team to Advance First-in-Class Pan-Cancer Therapeutics Targeting the ELANE Pathway into Clinical TrialsSee details»
Newsroom - ONCHILLES PHARMA
Jun 10, 2021 Onchilles Pharma pioneers the ELANE pathway to develop next-generation pan-cancer therapies. Explore our biologic pipeline for head & neck, skin, breast, and lung cancers, …See details»
Onchilles Expands Leadership Team to Advance First-in-Class
Jan 13, 2025 Onchilles’ pipeline is designed to address a range of cancers, including head & neck, skin, breast, and lung cancers, with first-in-human trials expected to begin in 2025. For …See details»
Onchilles Pharma Shares Promising Preclinical Data
Apr 23, 2024 SAN DIEGO – A treatment for cancer – all cancer, not just a specific tumor type – has been an elusive goal of pharmaceutical research since it began in the 1700s. Early this …See details»